No Data
Kunbo Medical-B (02216.HK): intends to repurchase shares in the market.
Gelonghui, December 12丨Kunbo Medical-B (02216.HK) announced that on December 12, 2024, the Board of Directors resolved to exercise the authority under the repurchase mandate to repurchase company shares from time to time on the open market. The proposed share repurchase will be funded using the company's existing available Cash / Money Market. The company will not conduct the repurchase if it would have a significant adverse effect on the company's working capital position. Subsequently, the company will cancel, hold as treasury shares, sell, or transfer repurchased shares (if any) as deemed appropriate by the Board of Directors. The company's current financial position is stable. The Board of Directors believes that the current Fill Price of the shares does not reflect their intrinsic value.
Express News | Broncus Holding Corp - - Intention to Conduct on-Market Share Repurchase
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
BRONCUS-B: Interim Report 2024
Kunbo Medical-B (2216.HK): Transformation breakthrough, resilient growth in the cold winter
In the capital winter, overseas medical instruments companies are facing unprecedented challenges.
102768097 : how to do?